1.
HNO
; 63(1): 60-2, 2015 Jan.
Article
in German
| MEDLINE
| ID: mdl-25604539
Subject(s)
Mouth Mucosa/pathology , Stomatitis, Aphthous/diagnosis , Stomatitis, Aphthous/etiology , Tuberculosis, Oral/complications , Tuberculosis, Oral/diagnosis , Diagnosis, Differential , Humans , Male , Middle Aged , Penicillins/therapeutic use , Stomatitis, Aphthous/drug therapy , Treatment Outcome , Tuberculosis, Oral/drug therapy
2.
HNO
; 62(4): 286-9, 2014 Apr.
Article
in German
| MEDLINE
| ID: mdl-24633382
Subject(s)
Maxillary Sinus Neoplasms/diagnosis , Maxillary Sinus Neoplasms/surgery , Odontogenic Tumors/diagnosis , Odontogenic Tumors/surgery , Radiography, Dental/methods , Referral and Consultation , Tooth Extraction , Adult , Combined Modality Therapy , Diagnosis, Differential , Diagnosis, Oral , Humans , Male , Organ Sparing Treatments , Treatment Outcome
3.
HNO
; 61(12): 1045-7, 2013 Dec.
Article
in German
| MEDLINE
| ID: mdl-24158714
4.
Infect Immun
; 69(11): 7194-6, 2001 Nov.
Article
in English
| MEDLINE
| ID: mdl-11598102
ABSTRACT
Clostridium perfringens mutant strain 121A/91 shows neither enzymatic (phospholipase C) nor hemolytic activity. Nevertheless, the cpa gene and the corresponding alpha-toxin variant are detectable. Vaccination with this genetically constructed alpha-toxin variant, rAT121/91, induces antibodies capable of significantly reducing activities induced by wild-type toxin. Thus, rAT121/91 could be a useful vaccine candidate.